Copyright
©The Author(s) 2024.
World J Radiol. Jul 28, 2024; 16(7): 256-264
Published online Jul 28, 2024. doi: 10.4329/wjr.v16.i7.256
Published online Jul 28, 2024. doi: 10.4329/wjr.v16.i7.256
Table 1 Patient characteristics, n (%)
| Characteristics (n = 259) | |
| Age (years) | |
| Median (range) | 71 (54-87) |
| Karnofsky performance status | |
| 100 | 232 (89.5) |
| 90 | 24 (9.3) |
| 80 | 1 (0.4) |
| 60 | 2 (0.8) |
| Follow-up time (months) | |
| Median (range) | 31 (14-40) |
| Initial prostate-specific antigen (ng/mL) | |
| Median (range) | 8.23 (0.62-1354) |
| T category | |
| 1b | 1 (0.4) |
| 1c | 39 (15.1) |
| 2a | 99 (38.2) |
| 2b | 34 (13.0) |
| 2c | 57 (22.0) |
| 3a | 19 (7.3) |
| 3b | 8 (3.1) |
| 4 | 2 (0.8) |
| Gleason score | |
| 6 | 39 (15.1) |
| 7 | 119 (45.9) |
| 8 | 65 (25.1) |
| 9 | 35 (13.5) |
| 10 | 1 (0.4) |
| Diabetes mellitus | |
| Yes | 29 (11.2) |
| No | 230 (88.8) |
| Anticoagulation therapy | |
| Yes | 38 (14.7) |
| No | 221 (85.3) |
| Androgen deprivation therapy | |
| Yes | 234 (90.3) |
| No | 25 (9.7) |
| Planning target volume (cc) | |
| Median (range) | 80.71 (43.24-202.60) |
- Citation: Ono T, Sato H, Miyasaka Y, Hagiwara Y, Yano N, Akamatsu H, Harada M, Ichikawa M. Correlation between dose-volume parameters and rectal bleeding after 12 fractions of carbon ion radiotherapy for prostate cancer. World J Radiol 2024; 16(7): 256-264
- URL: https://www.wjgnet.com/1949-8470/full/v16/i7/256.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i7.256